NCT04833946View on ClinicalTrials.gov

To Assess the Effect of 336 Days Exposure of Paractin® on Pain & Disease Progression in Patients Suffering From Osteoarthritis of Knee Joint.

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 13, 2021

Primary Completion Date

February 20, 2024

Study Completion Date

February 20, 2024

Conditions
Knee Osteoarthritis (Knee OA)
Interventions
OTHER

Andrographis paniculata [150 mg]

One capsule to be taken orally, 30 minutes after breakfast \& 30 minutes before bedtime

OTHER

Microcrystalline Cellulose (MCC)

One capsule to be taken orally, 30 minutes after breakfast \& 30 minutes before bedtime

Trial Locations (5)

30201

Asopa Hospital, Jaipur

221005

Shubham Sudbhawana Super Specialty Hospital, Varanasi

302017

Jaipur National University Institute for Medical Sciences and Research Center, Jaipur

400067

Ayush Nursing Home, Mumbai

401107

New Healthcare Nursing Home, Thāne

All Listed Sponsors
lead

Vedic Lifesciences Pvt. Ltd.

INDUSTRY

NCT04833946 - To Assess the Effect of 336 Days Exposure of Paractin® on Pain & Disease Progression in Patients Suffering From Osteoarthritis of Knee Joint. | Biotech Hunter | Biotech Hunter